logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
B

Blood and Lymphatic Cancer-Targets and Therapy

IF4.9
Papers51
Citations183
Journal Papers 53
Publication Date
delete
Efficacy and Safety of CLAG-Based Sequential Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Non-Remission Relapsed or Refractory Acute Leukemia
deleteBlood and Lymphatic Cancer-Targets and Therapy
IF4.9
delete2026-07-27
delete0
deleteOAAI
deleteShiyu Chen, Xiaohan Zhang, Xiaoqing Li, Xin Du
deleteShare
deleteSave
Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
deleteBlood and Lymphatic Cancer-Targets and Therapy
IF4.9
delete2026-07-15
delete0
deleteOAAI
deleteZixing Lu; Yayi Liu; Zhaoqing Jiang; Yu Zhu; Wenjie Liu; Qian Sun; Lei Fan; Sixuan Qian; Ming Hong
deleteShare
deleteSave
Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study
deleteBlood and Lymphatic Cancer-Targets and Therapy
IF4.9
delete2026-07-14
delete0
deleteOAAI
deleteChen Qiu; Tingting Zhang; Xuejing Yang; Yafang Guo; Zihui Gong; Dong Song
deleteShare
deleteSave
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
deleteBlood and Lymphatic Cancer-Targets and Therapy
IF4.9
delete2026-05-19
delete0
deleteOAAI
deleteAleksandra Kolosova; Imogen Anna Mould; Chris Pepper; Simon Mitchell; Andrea GS Pepper; Eleni E Ladikou; Fabio A Simoes
deleteShare
deleteSave
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort
deleteBlood and Lymphatic Cancer-Targets and Therapy
IF4.9
delete2026-01-01
delete0
deleteOAAI
deleteZhao, Na; Zhu, Lijun; Hu, Xing; Tong, Juan; Ge, Hongfeng; Ye, Li; Zhu, Xijun; Gai, Can; Feng, Yuhu; Zhang, Lei; Wang, Li; Sun, Guangyu; Xue, Lei; Zhu, Xiaoyu; Zheng, Changcheng
deleteShare
deleteSave
Comprehensive Analysis of Tumor Microenvironment and PD-L1 Expression Associations with Clinicopathological Features and Prognosis in Diffuse Large B-Cell Lymphoma
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-09-06
delete0
deleteOAAI
deleteYun-Li Xie; Long-Feng Ke; Wen-Wen Zhang; Fu Kang; Shu-Yi Lu; Chen-Yu Wu; Huan-Huan Zhu; Jian-Chao Wang; Gang Chen; Yan-Ping Chen
deleteShare
deleteSave
Comprehensive Evaluation of Drug-Related Problems and Pharmacotherapy Patterns in Non-Hodgkin’s Lymphoma Patients in Yemen
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-09-04
delete0
deleteOAAI
deleteMohammed Mohammed Battah; Hadzliana Zainal; Doa’a Anwar Ibrahim; Nur Hafzan Md Hanafiah; Syed Azhar Syed Sulaiman
deleteShare
deleteSave
Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-08-30
delete0
deleteOAAI
deleteMengyuan Gu; Yanting Zheng; Yifan Wang; Qicai Wang; Jing Wu; Zengyi Xiong; Yanyu Nong; Chunni Huang; Zhongqing Li; Jun Luo; Zhian Ling; Ruolin Li
deleteShare
deleteSave
Neutrophil-Related Genes Predict Prognosis and Contribute to Immunosuppression in Acute Myeloid Leukemia
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-08-18
delete0
deleteOAAI
deleteDi Zhang, Yongjian Li, Tingting Liu, Xiaomin Liu, Jingru Zhang
deleteShare
deleteSave
Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-08-01
delete0
deleteOAAI
deleteLiangquan Geng; Erling Chen; Yanping Ji; Huilan Liu; Zimin Sun
deleteShare
deleteSave
Clinical Characteristics; Prognostic Risk Factors; and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-07-07
delete0
deleteOAAI
deleteMengyao Zhang; Runyu Yang; Yue Du; Hui Feng, Yi Liu, Haibo Liu, Di Wu, Fan Niu, Pengcheng He
deleteShare
deleteSave
Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast]
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-07-02
delete0
deleteOAAI
deleteAmer M Zeidan; Eunice Wang
deleteShare
deleteSave
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-07-02
delete0
deleteOAAI
deleteAmer M Zeidan; Courtney DiNardo
deleteShare
deleteSave
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-06-24
delete0
deleteOAAI
deleteEmmanuel Ifeanyi Obeagu
deleteShare
deleteSave
Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists [Podcast]
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-06-21
delete0
deleteOAAI
deleteAmer M Zeidan; Sanam Loghavi
deleteShare
deleteSave
A Monocyte-Driven Prognostic Model for Multiple Myeloma: Multi-Omics and Machine Learning Insights
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-06-16
delete0
deleteOAAI
deleteLinzhi Xie; Meng Gao; Shiming Tan; Yi Zhou; Jing Liu; Liwen Wang; Xin Li
deleteShare
deleteSave
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
deleteblood and lymphatic cancer targets and therapy
IF0
delete2025-06-05
delete0
deleteOAAI
deleteLuciano J Costa; Thomas W LeBlanc; Hans Tesch; Pieter Sonneveld; Sarasa MA Johnson; Francis Vekeman; Patrick Hlavacek; Aster Meche; Chai Hyun Kim; Paul Cislo; David M Hughes; Guido Nador; Marco DiBonaventura
deleteShare
deleteSave
T-Cell Engagers In Multiple Myeloma: A Clinical Review
deleteBLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
IF4.9
delete2025-01-01
delete0
deleteOAAI
deleteAl-Jarrad, Ahmad; Alouch, Samhar Samer; Chawla, Yogesh; Gonsalves, Wilson, I
deleteShare
deleteSave
The Antibody Drug Conjugate; Belantamab-Mafodotin; in the Treatment of Multiple Myeloma: A Comprehensive Review
deleteblood and lymphatic cancer targets and therapy
IF0
delete2024-12-06
delete0
deleteOAAI
deleteAdrian Alfonso Almodovar Diaz; Samhar Samer Alouch; Yogesh Chawla, Wilson I Gonsalves
deleteShare
deleteSave
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
deleteBLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
IF4.9
delete2024-07-01
delete0
deleteOAAI
deleteLiu, Dan; Tong, Juan; Chen, Erling; Wang, Li; Xue, Lei; Zhang, Xuhan; Zhao, Na; Hu, Xing; Zheng, Changcheng
deleteShare
deleteSave